Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3780)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$569.61
Total Value
$60.38K
Shares Held After
41,528
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$568.16
Total Value
$204.54K
Shares Held After
41,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$567.21
Total Value
$180.94K
Shares Held After
41,994
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
705
Price
$565.99
Total Value
$399.02K
Shares Held After
42,313
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,983
Price
$564.77
Total Value
$1.12M
Shares Held After
43,018
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,864
Price
$564.00
Total Value
$1.05M
Shares Held After
45,001
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,022
Price
$563.06
Total Value
$1.14M
Shares Held After
46,865
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,126
Price
$562.08
Total Value
$632.91K
Shares Held After
48,887
% of Holdings
2.3%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
15,003
Price
$38.30
Total Value
$574.61K
Shares Held After
14,769
% of Holdings
50.4%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
55,000
Price
$38.38
Total Value
$2.11M
Shares Held After
14,769
% of Holdings
78.8%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$30.00
Total Value
$300.00K
Shares Held After
134,985
% of Holdings
6.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
19,269
Price
$75.35
Total Value
$1.45M
Shares Held After
88,606
% of Holdings
17.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
24,814
Price
$74.76
Total Value
$1.86M
Shares Held After
107,875
% of Holdings
18.7%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
33,513
Price
$73.72
Total Value
$2.47M
Shares Held After
132,689
% of Holdings
20.2%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,404
Price
$72.57
Total Value
$174.46K
Shares Held After
166,202
% of Holdings
1.4%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
117
Price
$29.10
Total Value
$3.40K
Shares Held After
346,059
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
4,321
Price
$28.52
Total Value
$123.23K
Shares Held After
346,176
% of Holdings
1.2%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
721
Price
$28.28
Total Value
$20.39K
Shares Held After
242,729
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
5,220
Price
$29.15
Total Value
$152.16K
Shares Held After
1,560,720
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
14,880
Price
$28.47
Total Value
$423.63K
Shares Held After
1,565,940
% of Holdings
0.9%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
12,000
Price
$100.07
Total Value
$1.20M
Shares Held After
6,000
% of Holdings
66.7%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
36,000
Price
$100.14
Total Value
$3.61M
Shares Held After
27,825
% of Holdings
56.4%
Cellectar Biosciences, Inc. (CLRB)
CARUSO JAMES V — Director
Shares
8,680
Price
$2.88
Total Value
$25.00K
Shares Held After
20,318
% of Holdings
42.7%
Cellectar Biosciences, Inc. (CLRB)
Longcor Jarrod — Chief Operating Officer
Shares
8,680
Price
$2.88
Total Value
$25.00K
Shares Held After
20,451
% of Holdings
42.4%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Chaudhuri Sarbani — Chief Commercial & Medical Affairs Officer
Shares
17,650
Price
$3.84
Total Value
$67.74K
Shares Held After
267,510
% of Holdings
6.2%
Atara Biotherapeutics, Inc. (ATRA)
Panacea Innovation Ltd — 10% Owner
Shares
313,446
Price
$10.10
Total Value
$3.17M
Shares Held After
1,011,000
% of Holdings
23.7%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
48,546
Price
$44.61
Total Value
$2.17M
Shares Held After
2,916,228
% of Holdings
1.6%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
48,546
Price
$44.61
Total Value
$2.17M
Shares Held After
2,916,228
% of Holdings
1.6%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
18,606
Price
$24.12
Total Value
$448.82K
Shares Held After
423
% of Holdings
97.8%
Aura Biosciences, Inc. (AURA)
Matrix Capital Management Company, LP — 10% Owner
Shares
6,922,870
Price
$5.64
Total Value
$39.04M
Shares Held After
0
% of Holdings
100.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
449
Price
$69.09
Total Value
$31.02K
Shares Held After
4,378,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,334
Price
$68.38
Total Value
$569.86K
Shares Held After
4,378,896
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
11,217
Price
$67.49
Total Value
$757.09K
Shares Held After
4,387,230
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
450
Price
$69.09
Total Value
$31.09K
Shares Held After
575,686
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,333
Price
$68.38
Total Value
$569.79K
Shares Held After
576,136
% of Holdings
1.4%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
11,217
Price
$67.50
Total Value
$757.09K
Shares Held After
584,469
% of Holdings
1.9%
Atara Biotherapeutics, Inc. (ATRA)
EcoR1 Capital, LLC — 10% Owner
Shares
507,407
Price
$9.35
Total Value
$4.74M
Shares Held After
1,552,000
% of Holdings
32.7%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Friberg Gregory R — EVP, Chief R&D Officer
Shares
3,281
Price
$53.85
Total Value
$176.68K
Shares Held After
51,818
% of Holdings
6.0%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
271,495
Price
$40.12
Total Value
$10.89M
Shares Held After
6,437,733
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$597.54
Total Value
$95.61K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$589.63
Total Value
$94.34K
Shares Held After
40,673
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$588.86
Total Value
$188.43K
Shares Held After
40,833
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
545
Price
$587.71
Total Value
$320.30K
Shares Held After
41,153
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
375
Price
$586.84
Total Value
$220.06K
Shares Held After
41,698
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
512
Price
$585.83
Total Value
$299.95K
Shares Held After
42,073
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
208
Price
$584.57
Total Value
$121.59K
Shares Held After
42,585
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$583.65
Total Value
$256.80K
Shares Held After
42,793
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
171
Price
$581.47
Total Value
$99.43K
Shares Held After
43,233
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
509
Price
$580.55
Total Value
$295.50K
Shares Held After
43,404
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$579.11
Total Value
$69.49K
Shares Held After
43,913
% of Holdings
0.3%
Showing 1601–1650 of 3780 transactions (page 33 of 76)